Procurement Summary
Country : Brazil
Summary : Acquisition of Gencitabine (Hydrochloride) 1000 Mg Po Liof for Sol Inj Fa, Irinotecan (Hydrochloride) 20 Mg/Ml Injectable Solution Fa 5 Ml, Ibuprofen 300 Mg Tablet, Sodium Hyaluronate 10 Mg/Ml Solution ...
Deadline : 23 Apr 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 117488162
Document Ref. No. : 90285/2025
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Acquisition of Gencitabine (Hydrochloride) 1000 mg Po Lion for Sol Inj FA, Irinotecan (Hydrochloride) 20 mg/ml Injectable Solution FA 5 ml, ibuprofen 300 mg Compressed, Sodium Hialuronate 10 mg/ml Injectable Solution FA 2 ml INJ VASCAMPOLAS, Hydroxypropylmethylcellulose 2 % Syringe 1.5 ml, sulfur hexafluoride 8 mcl/ml be 5ml, Sodium Hialuronate 75 mg/3ml SER
UASG Code: 92301
Notice from: 09/04/2025 from 08:00 to 17:59 hs
Delivery of the proposal: from 09/04/2025 at 08: 00hs
Gencitabine Hydrochloride, dosage 1g, type useInjectable
Quantity: 40
Irinotecan Hydrochloride, dosage 20 mg/ml, pharmaceutical form injectable solution
Quantity: 60
ibuprofen, dosage 300 mg
quantity: 55256
hialuronate sodium, quantity 10 mg/ml, pharmaceutical formFilled
Quantity: 728
Green Indocyanin, concentration 25 mg, pharmaceutical form for ophthalmic solution, additional characteristic with diluent ampoule
quantity: 20
methylcellulose, 2%concentration, type of intraocular solution
quantity: 8354
radiological contrast, dispersion type of dispersion ofMicrobolhas, composition based on sulfur hexafluoride, concentration 8 mcl/ml, pharmaceutical shape Liofilo powder for injectable + diluent
Quantity: 308
Hialuronate of sodium, quantity 25 mg/mL, pharmaceutical form, intra-articular solution, additional syringe characteristicFilled
Quantity: 208
Documents
Tender Notice